Biogen, Elan Suspend Tysabri After Death (Reuters)


Reuters - Biogen Idec and Elan Corporation Plc
on Monday suspended sales of their much-heralded new multiple
sclerosis drug Tysabri after a patient died from a rare but
frequently fatal central nervous system disease.

Read more...